HER2-low breast cancer patients with the HR-positive subtype showed fewer T4 tumours, higher histologic profile and negative lymphatic invasion in contrast to HER2-low TNBC patients who have higher lymph node ratios and presentation of positive lymphatic invasion. The gene discussed is ERBB2; the disease is breast carcinoma.